Takeda Pharmaceutical Company Limited 13D and 13G filings for HilleVax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-19 07:22 am Sale | 2025-09-17 | 13D | HilleVax, Inc. HLVX | Takeda Pharmaceutical Company Limited | 0 0.000% | -6,724,000 (Position Closed) | Filing |
| 2022-05-09 06:08 am Purchase | 2022-04-28 | 13D | HilleVax, Inc. HLVX | Takeda Pharmaceutical Company Limited | 6,724,000 17.100% | 6,724,000 (New Position) | Filing |